This inventor holds 1 USPTO granted patent. Top assignee: Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.v.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Karsten Mäder: Innovator in Tetracycline Antibiotics
Introduction
Karsten Mäder is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tetracycline antibiotics. His innovative work focuses on enhancing the efficacy and delivery of these important medications.
Latest Patents
Karsten Mäder holds a patent for "Tetracycline complexes with sustained activity." This invention relates to the controlled release of tetracycline antibiotics. Specifically, it involves a complex comprising a tetracycline compound or a pharmaceutically acceptable salt, hydrate, or solvate thereof, along with a divalent metal carboxylate. The patent outlines a pharmaceutical preparation that maintains antibiotic activity over a prolonged period, making it particularly useful for treating bacterial infections and managing periodontal diseases.
Career Highlights
Mäder is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in applied sciences. His work at this institution has allowed him to focus on innovative solutions in the pharmaceutical sector. With a patent portfolio that includes 1 patent, he continues to push the boundaries of antibiotic research.
Collaborations
Throughout his career, Karsten Mäder has collaborated with talented professionals such as Sandra Sarembe and Martin Kirchberg. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.
Conclusion
Karsten Mäder's contributions to the field of tetracycline antibiotics exemplify the importance of innovation in healthcare. His work not only advances medical science but also improves treatment options for patients suffering from bacterial infections.